本文選題：左西孟坦 + 瓣膜置換術��； 參考：《中國現(xiàn)代醫(yī)學雜志》2017年09期

【摘要】：目的觀察左西孟坦在瓣膜置換術后應用的臨床效果。方法二尖瓣置換術患者60例,隨機分為常規(guī)治療組和左西孟坦組,每組30例。術后常規(guī)治療組給予強心、利尿等常規(guī)治療,左西孟坦組在常規(guī)治療組治療基礎上給予左西孟坦。比較兩組患者治療效果及恢復情況。結果術后左西孟坦組心肌損傷反應和呼吸機輔助時間與常規(guī)治療組比較,差異有統(tǒng)計學意義(P0.05),左西孟坦組心肌損傷反應和呼吸機輔助時間減少;左西孟坦組重癥加強護理病房(ICU)停留時間與常規(guī)治療組比較,差異有統(tǒng)計學意義(P0.05),左西孟坦組ICU停留時間減少。結論左西孟坦用于心臟瓣膜置換術后患者可明顯改善心功能,減輕心肌損傷反應,且不良反應少,值得臨床推廣。
[Abstract]:Objective to observe the clinical effect of levsimengtan after valvular replacement.Methods Sixty patients with mitral valve replacement were randomly divided into conventional treatment group and left West Montan group with 30 cases in each group.Postoperative routine treatment group was given cardiac, diuretic and other routine treatment, the left West Montan group on the basis of routine treatment group, levoximentam group.The curative effect and recovery were compared between the two groups.Results compared with the routine treatment group, the myocardial injury response and the ventilator assisted time in the left West Montan group were significantly different from those in the conventional treatment group (P 0.05), but the myocardial injury response and the ventilator assisted time in the left West Montan group were lower than those in the conventional treatment group.Compared with the routine treatment group, there was a significant difference between the left West Montan group and the routine treatment group (P 0.05). The ICU residence time in the left West Montan group was decreased.Conclusion Levamentam can significantly improve cardiac function and alleviate myocardial injury reaction after valvular replacement, and has less adverse reactions, so it is worth popularizing in clinic.
【作者單位】： 中國人民解放軍91中心醫(yī)院心胸外科重癥加強護理病房;鄭州大學第一附屬醫(yī)院重癥醫(yī)學科;
【分類號】：R654.2

【相似文獻】

相關期刊論文 前1條

1 王曉瑜;;術前左西孟坦灌注在動脈瓣及冠狀動脈旁路手術中的作用[J];山東醫(yī)藥;2011年04期

，

本文編號：1738172